| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | steroid sulfotransferase activity | 8.25e-12 | 7 | 208 | 6 | GO:0050294 | |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 1.17e-10 | 5 | 208 | 5 | GO:0047894 | |
| GeneOntologyMolecularFunction | aryl sulfotransferase activity | 2.41e-10 | 10 | 208 | 6 | GO:0004062 | |
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 1.14e-08 | 4 | 208 | 4 | GO:0017067 | |
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 1.14e-08 | 4 | 208 | 4 | GO:0047685 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 HS3ST4 SULT1A4 | 9.69e-08 | 55 | 208 | 8 | GO:0008146 |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 HS3ST4 SULT1A4 | 1.01e-06 | 74 | 208 | 8 | GO:0016782 |
| GeneOntologyMolecularFunction | sulfate binding | 1.38e-06 | 9 | 208 | 4 | GO:0043199 | |
| GeneOntologyMolecularFunction | 3'-phosphoadenosine 5'-phosphosulfate binding | 7.60e-06 | 13 | 208 | 4 | GO:0050656 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.12e-05 | 18 | 208 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.92e-04 | 28 | 208 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR6N2 OR2W1 PTGER4 OR6B3 CCR6 GPR171 LTB4R CNR1 VN1R2 HTR1A OR6Q1 FPR3 GRM8 OR6A2 P2RY1 OR52E8 OR5H2 OR6K3 OR6B2 OR52B6 GABBR1 | 3.83e-04 | 884 | 208 | 21 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | EPHB4 OR6N2 OR2W1 PTGER4 RYK NRXN3 OR6B3 PTPRH CCR6 GPR171 LTB4R CNR1 VN1R2 CHRNA6 IL31RA HTR1A OR6Q1 FPR3 RET GRM8 OR6A2 P2RY1 OR52E8 OR5H2 OR6K3 OR6B2 OR52B6 GABBR1 | 3.93e-04 | 1353 | 208 | 28 | GO:0004888 |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 4.62e-04 | 15 | 208 | 3 | GO:0010484 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 4.62e-04 | 15 | 208 | 3 | GO:0016725 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 5.77e-04 | 37 | 208 | 4 | GO:0045505 | |
| GeneOntologyBiologicalProcess | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 1.77e-10 | 17 | 209 | 7 | GO:0050427 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside bisphosphate metabolic process | 1.77e-10 | 17 | 209 | 7 | GO:0034035 | |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate metabolic process | PDK3 HMGCR SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 ACSBG2 ABCD1 SULT1A4 AASS HSD17B12 | 2.26e-09 | 142 | 209 | 13 | GO:0033865 |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate metabolic process | PDK3 HMGCR SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 ACSBG2 ABCD1 SULT1A4 AASS HSD17B12 | 2.26e-09 | 142 | 209 | 13 | GO:0033875 |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate metabolic process | PDK3 HMGCR SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 ACSBG2 ABCD1 SULT1A4 AASS HSD17B12 | 2.26e-09 | 142 | 209 | 13 | GO:0034032 |
| GeneOntologyBiologicalProcess | sulfation | 7.42e-09 | 27 | 209 | 7 | GO:0051923 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 1.14e-08 | 17 | 209 | 6 | GO:0006068 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 1.69e-08 | 18 | 209 | 6 | GO:0006067 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | CYP1A2 CYP3A5 SULT1E1 SULT1A2 SULT1A1 SULT1A3 SULT1A4 HSD17B12 | 4.99e-08 | 52 | 209 | 8 | GO:0008210 |
| GeneOntologyBiologicalProcess | 4-nitrophenol metabolic process | 5.08e-08 | 5 | 209 | 4 | GO:0018960 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 8.81e-08 | 23 | 209 | 6 | GO:0034310 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 4.42e-07 | 47 | 209 | 7 | GO:0046164 | |
| GeneOntologyBiologicalProcess | sulfur compound metabolic process | PDK3 MCCC1 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 ACSBG2 ABCD1 HS3ST4 TCF7L2 FMO3 SULT1A4 AASS HSD17B12 | 1.06e-06 | 365 | 209 | 16 | GO:0006790 |
| GeneOntologyBiologicalProcess | alcohol metabolic process | CYP1A2 MOGAT1 CYP3A5 HMGCR SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 GPD2 GBA2 LIPA SULT1A4 RDH16 P2RY1 LSS | 1.11e-06 | 412 | 209 | 17 | GO:0006066 |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | CYP1A2 CYP3A5 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT1A4 RDH16 | 1.33e-06 | 106 | 209 | 9 | GO:0034308 |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | PDK3 SERINC2 HMGCR ACTN3 RRM1 NDUFS5 SULT1E1 SULT1A2 SULT1B1 SMPDL3B SULT1A1 SULT1A3 SULT2B1 PIK3CA PIK3CD SIK2 ETNK1 ACSBG2 ABCD1 GPD2 OGT INPP5F TMEM38B LIPA SULT1A4 P2RY1 AASS DDHD1 HSD17B12 NNT | 1.62e-06 | 1142 | 209 | 30 | GO:0019637 |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | CYP1A2 CYP3A5 CES2 ABCB1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 FMO3 SULT1A4 | 1.79e-06 | 141 | 209 | 10 | GO:0006805 |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | UAP1 PDK3 HMGCR ACTN3 RRM1 PTGER4 ITIH4 NDUFS5 CES2 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 SIK2 ACSBG2 ABCD1 HS3ST4 GPD2 TCF7L2 STAB2 OGT PLOD3 CNMD GBA2 LIPA SULT1A4 AASS CST3 HSD17B12 | 2.35e-06 | 1226 | 209 | 31 | GO:1901135 |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | SOX10 CYP1A2 CYP3A5 CES2 ABCB1 FANCB SULT1A2 SULT1B1 SULT1A1 SULT1A3 FMO3 SULT1A4 | 2.94e-06 | 222 | 209 | 12 | GO:0071466 |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | PDK3 HMGCR ACTN3 NDUFS5 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 SIK2 ACSBG2 ABCD1 OGT LIPA SULT1A4 AASS HSD17B12 | 5.11e-06 | 512 | 209 | 18 | GO:0009150 |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | PDK3 HMGCR ACTN3 NDUFS5 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 SIK2 ACSBG2 ABCD1 GPD2 OGT LIPA SULT1A4 AASS HSD17B12 NNT | 5.32e-06 | 619 | 209 | 20 | GO:0006163 |
| GeneOntologyBiologicalProcess | regulation of hormone levels | CYP1A2 CYP3A5 HMGCR FOXA1 PTGER4 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 CNR1 FOXO1 TCF7L2 HTR1A STXBP5L SULT1A4 RDH16 P2RY1 SYTL4 HSD17B12 GABBR1 | 6.72e-06 | 684 | 209 | 21 | GO:0010817 |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | PDK3 HMGCR ACTN3 RRM1 NDUFS5 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 SIK2 ACSBG2 ABCD1 GPD2 OGT LIPA SULT1A4 AASS HSD17B12 NNT | 6.72e-06 | 684 | 209 | 21 | GO:0009117 |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 6.82e-06 | 13 | 209 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | PDK3 HMGCR ACTN3 RRM1 NDUFS5 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 SIK2 ACSBG2 ABCD1 GPD2 OGT LIPA SULT1A4 AASS HSD17B12 NNT | 7.85e-06 | 691 | 209 | 21 | GO:0006753 |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | PDK3 HMGCR ACTN3 NDUFS5 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 SIK2 ACSBG2 ABCD1 OGT LIPA SULT1A4 AASS HSD17B12 | 8.85e-06 | 533 | 209 | 18 | GO:0009259 |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | CYP1A2 MOGAT1 CYP3A5 HMGCR ACTN3 DDT SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 GPD2 HTR1A GBA2 LIPA SULT1A4 RDH16 P2RY1 LSS | 8.90e-06 | 641 | 209 | 20 | GO:1901615 |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 9.17e-06 | 73 | 209 | 7 | GO:1901616 | |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | PDK3 HMGCR ACTN3 NDUFS5 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 SIK2 ACSBG2 ABCD1 OGT LIPA SULT1A4 AASS HSD17B12 | 1.06e-05 | 540 | 209 | 18 | GO:0019693 |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | PDK3 HMGCR ACTN3 NDUFS5 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 SIK2 ACSBG2 ABCD1 GPD2 OGT LIPA SULT1A4 AASS HSD17B12 NNT | 1.14e-05 | 652 | 209 | 20 | GO:0072521 |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | UAP1 PDK3 HMGCR ACTN3 RRM1 NDUFS5 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 SIK2 ACSBG2 ABCD1 GPD2 OGT LIPA SULT1A4 AASS HSD17B12 NNT | 1.17e-05 | 767 | 209 | 22 | GO:0055086 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | CYP1A2 CYP3A5 PDK3 ACTN3 MCCC1 CES2 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 GLDC SIK2 ACSBG2 ABCD1 CNR1 FMO3 OGT PLOD3 GBA2 LIPA SULT1A4 RDH16 AASS HSD17B12 | 2.99e-05 | 1064 | 209 | 26 | GO:0006082 |
| GeneOntologyBiologicalProcess | steroid metabolic process | CYP1A2 CYP3A5 HMGCR SULT1E1 SULT1A2 SULT1A1 SULT1A3 SULT2B1 GBA2 LIPA SULT1A4 RDH16 HSD17B12 LSS | 3.17e-05 | 376 | 209 | 14 | GO:0008202 |
| GeneOntologyBiologicalProcess | hormone metabolic process | CYP1A2 CYP3A5 FOXA1 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 TCF7L2 SULT1A4 RDH16 HSD17B12 | 3.74e-05 | 286 | 209 | 12 | GO:0042445 |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid secretion | 4.37e-05 | 20 | 209 | 4 | GO:0014051 | |
| GeneOntologyBiologicalProcess | negative regulation of amine transport | 7.17e-05 | 43 | 209 | 5 | GO:0051953 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | CYP1A2 CYP3A5 PDK3 ACTN3 MCCC1 CES2 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 GLDC SIK2 ACSBG2 ABCD1 CNR1 OGT PLOD3 GBA2 LIPA SULT1A4 RDH16 AASS HSD17B12 | 7.37e-05 | 1058 | 209 | 25 | GO:0043436 |
| GeneOntologyBiologicalProcess | phenol-containing compound metabolic process | 1.02e-04 | 142 | 209 | 8 | GO:0018958 | |
| GeneOntologyBiologicalProcess | small molecule catabolic process | ACTN3 MCCC1 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 GLDC ACSBG2 ABCD1 CNR1 GPD2 SULT1A4 AASS | 1.06e-04 | 421 | 209 | 14 | GO:0044282 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling, modulating synaptic transmission | 1.29e-04 | 26 | 209 | 4 | GO:0099550 | |
| GeneOntologyBiologicalProcess | negative regulation of secretion | HMGCR PTGER4 NF1 CNR1 FOXO1 HTR1A STXBP5L P2RY1 SYTL4 GABBR1 | 1.71e-04 | 239 | 209 | 10 | GO:0051048 |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid transport | 1.73e-04 | 28 | 209 | 4 | GO:0015812 | |
| GeneOntologyBiologicalProcess | signal release from synapse | 1.74e-04 | 195 | 209 | 9 | GO:0099643 | |
| GeneOntologyBiologicalProcess | neurotransmitter secretion | 1.74e-04 | 195 | 209 | 9 | GO:0007269 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid secretion, neurotransmission | 3.05e-04 | 3 | 209 | 2 | GO:0061534 | |
| GeneOntologyBiologicalProcess | fatty-acyl-CoA transport | 3.05e-04 | 3 | 209 | 2 | GO:0015916 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular associated smooth muscle contraction | 3.05e-04 | 3 | 209 | 2 | GO:1904694 | |
| GeneOntologyBiologicalProcess | thioester transport | 3.05e-04 | 3 | 209 | 2 | GO:1901337 | |
| GeneOntologyBiologicalProcess | signal release | HMGCR PTGER4 NRXN3 NF1 STXBP2 CNR1 FOXO1 CHRNA6 TCF7L2 HTR1A STXBP5L GRM8 P2RY1 SYTL4 PAK1 RIMS1 GABBR1 | 3.73e-04 | 653 | 209 | 17 | GO:0023061 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | PSEN2 CACNA2D2 HMGCR PTGER4 NRXN3 NF1 PLAT CNR1 CHRNA6 HTR1A STXBP5L ZDHHC17 GRM8 P2RY1 PAK1 RIMS1 GABBR1 | 4.43e-04 | 663 | 209 | 17 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | PSEN2 CACNA2D2 HMGCR PTGER4 NRXN3 NF1 PLAT CNR1 CHRNA6 HTR1A STXBP5L ZDHHC17 GRM8 P2RY1 PAK1 RIMS1 GABBR1 | 4.50e-04 | 664 | 209 | 17 | GO:0099177 |
| GeneOntologyBiologicalProcess | muscle system process | ARHGAP42 DOCK4 PSEN2 ACTN3 PTGER4 PIK3CA SRL COL14A1 LTB4R FOXO1 INPP5F TMEM38B P2RY1 PAK1 MYOM2 | 4.84e-04 | 547 | 209 | 15 | GO:0003012 |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 6.03e-04 | 231 | 209 | 9 | GO:0006109 | |
| GeneOntologyCellularComponent | presynaptic membrane | PSEN2 CACNA2D2 RYK NRXN3 CNR1 CHRNA6 IL31RA HTR1A ZDHHC17 GRM8 P2RY1 RIMS1 GABBR1 | 4.89e-06 | 277 | 210 | 13 | GO:0042734 |
| GeneOntologyCellularComponent | GABA-ergic synapse | 4.34e-05 | 164 | 210 | 9 | GO:0098982 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.06e-04 | 25 | 210 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.14e-04 | 10 | 210 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 1.35e-04 | 78 | 210 | 6 | GO:0048787 | |
| GeneOntologyCellularComponent | interstitial matrix | 6.13e-04 | 17 | 210 | 3 | GO:0005614 | |
| Domain | Sulfotransfer_1 | SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 HS3ST4 SULT1A4 | 5.16e-09 | 36 | 210 | 8 | PF00685 |
| Domain | Sulfotransferase_dom | SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 HS3ST4 SULT1A4 | 5.16e-09 | 36 | 210 | 8 | IPR000863 |
| Domain | Dynein_HC_stalk | 1.42e-05 | 14 | 210 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.42e-05 | 14 | 210 | 4 | IPR013602 | |
| Domain | DHC_N2 | 1.42e-05 | 14 | 210 | 4 | PF08393 | |
| Domain | MT | 1.42e-05 | 14 | 210 | 4 | PF12777 | |
| Domain | DHC_fam | 1.92e-05 | 15 | 210 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 1.92e-05 | 15 | 210 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.92e-05 | 15 | 210 | 4 | IPR004273 | |
| Domain | Lipase_euk | 2.73e-05 | 6 | 210 | 3 | IPR025483 | |
| Domain | Abhydro_lipase | 2.73e-05 | 6 | 210 | 3 | PF04083 | |
| Domain | AB_hydrolase_lipase | 2.73e-05 | 6 | 210 | 3 | IPR006693 | |
| Domain | Med12 | 1.26e-04 | 2 | 210 | 2 | PF09497 | |
| Domain | Mediator_Med12_catenin-bd | 1.26e-04 | 2 | 210 | 2 | IPR021989 | |
| Domain | AlaDh_PNT_C | 1.26e-04 | 2 | 210 | 2 | PF01262 | |
| Domain | AlaDH/PNT_N | 1.26e-04 | 2 | 210 | 2 | IPR007886 | |
| Domain | Med12-PQL | 1.26e-04 | 2 | 210 | 2 | PF12144 | |
| Domain | Med12-LCEWAV | 1.26e-04 | 2 | 210 | 2 | PF12145 | |
| Domain | Med12 | 1.26e-04 | 2 | 210 | 2 | SM01281 | |
| Domain | AlaDh_PNT_N | 1.26e-04 | 2 | 210 | 2 | PF05222 | |
| Domain | AlaDh_PNT_N | 1.26e-04 | 2 | 210 | 2 | SM01003 | |
| Domain | AlaDh_PNT_C | 1.26e-04 | 2 | 210 | 2 | SM01002 | |
| Domain | Aquaporin_12 | 1.26e-04 | 2 | 210 | 2 | IPR023265 | |
| Domain | Mediator_Med12 | 1.26e-04 | 2 | 210 | 2 | IPR019035 | |
| Domain | ALADH_PNT_1 | 1.26e-04 | 2 | 210 | 2 | PS00836 | |
| Domain | ALADH_PNT_2 | 1.26e-04 | 2 | 210 | 2 | PS00837 | |
| Domain | AlaDH/PNT_NAD(H)-bd | 1.26e-04 | 2 | 210 | 2 | IPR007698 | |
| Domain | Mediator_Med12_LCEWAV | 1.26e-04 | 2 | 210 | 2 | IPR021990 | |
| Domain | GPCR_Rhodpsn_7TM | OR6N2 OR2W1 PTGER4 OR6B3 CCR6 GPR171 LTB4R CNR1 VN1R2 HTR1A OR6Q1 FPR3 OR6A2 P2RY1 OR52E8 OR5H2 OR6K3 OR6B2 OR52B6 | 2.11e-04 | 670 | 210 | 19 | IPR017452 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR6N2 OR2W1 PTGER4 OR6B3 CCR6 GPR171 LTB4R CNR1 VN1R2 HTR1A OR6Q1 FPR3 OR6A2 P2RY1 OR52E8 OR5H2 OR6K3 OR6B2 OR52B6 | 2.79e-04 | 685 | 210 | 19 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR6N2 OR2W1 PTGER4 OR6B3 CCR6 GPR171 LTB4R CNR1 VN1R2 HTR1A OR6Q1 FPR3 OR6A2 P2RY1 OR52E8 OR5H2 OR6K3 OR6B2 OR52B6 | 3.11e-04 | 691 | 210 | 19 | PS50262 |
| Domain | GPCR_Rhodpsn | OR6N2 OR2W1 PTGER4 OR6B3 CCR6 GPR171 LTB4R CNR1 VN1R2 HTR1A OR6Q1 FPR3 OR6A2 P2RY1 OR52E8 OR5H2 OR6K3 OR6B2 OR52B6 | 3.16e-04 | 692 | 210 | 19 | IPR000276 |
| Domain | PI3K_p85B | 3.75e-04 | 3 | 210 | 2 | PF02192 | |
| Domain | PI3K_p85B | 3.75e-04 | 3 | 210 | 2 | SM00143 | |
| Domain | Aquaporin_11/12 | 3.75e-04 | 3 | 210 | 2 | IPR016697 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.65e-04 | 14 | 210 | 3 | IPR024317 | |
| Domain | ATPase_dyneun-rel_AAA | 4.65e-04 | 14 | 210 | 3 | IPR011704 | |
| Domain | AAA_8 | 4.65e-04 | 14 | 210 | 3 | PF12780 | |
| Domain | AAA_5 | 4.65e-04 | 14 | 210 | 3 | PF07728 | |
| Domain | fn3 | 5.03e-04 | 162 | 210 | 8 | PF00041 | |
| Domain | 7tm_1 | OR6N2 OR2W1 PTGER4 OR6B3 CCR6 GPR171 LTB4R CNR1 HTR1A OR6Q1 FPR3 OR6A2 P2RY1 OR52E8 OR5H2 OR6K3 OR6B2 OR52B6 | 6.63e-04 | 677 | 210 | 18 | PF00001 |
| Domain | PI3K_ABD | 7.44e-04 | 4 | 210 | 2 | PS51544 | |
| Domain | PI3K_adapt-bd_dom | 7.44e-04 | 4 | 210 | 2 | IPR003113 | |
| Domain | - | ABCA13 ZRANB3 ABCB1 EHD4 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT2B1 SRL ABCD1 HS3ST4 DNAH9 DNHD1 DHX58 DNAH10 NSF DNAH1 MCM9 | 7.88e-04 | 746 | 210 | 19 | 3.40.50.300 |
| Domain | FN3 | 1.19e-03 | 185 | 210 | 8 | SM00060 | |
| Domain | HAT_MYST-type | 1.23e-03 | 5 | 210 | 2 | IPR002717 | |
| Domain | EHD_N | 1.23e-03 | 5 | 210 | 2 | IPR031692 | |
| Domain | MOZ_SAS | 1.23e-03 | 5 | 210 | 2 | PF01853 | |
| Domain | EHD_N | 1.23e-03 | 5 | 210 | 2 | PF16880 | |
| Domain | MYST_HAT | 1.23e-03 | 5 | 210 | 2 | PS51726 | |
| Domain | AAA | 1.23e-03 | 144 | 210 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 1.23e-03 | 144 | 210 | 7 | IPR003593 | |
| Domain | - | 1.47e-03 | 74 | 210 | 5 | 3.40.50.410 | |
| Domain | PAK_BD | 1.83e-03 | 6 | 210 | 2 | IPR033923 | |
| Domain | FN3 | 1.90e-03 | 199 | 210 | 8 | PS50853 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS | 2.13e-10 | 5 | 166 | 5 | M47807 | |
| Pathway | KEGG_SULFUR_METABOLISM | 3.90e-09 | 13 | 166 | 6 | M18256 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 5.79e-09 | 23 | 166 | 7 | MM14597 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 8.09e-09 | 24 | 166 | 7 | M16289 | |
| Pathway | WP_SULFATION_BIOTRANSFORMATION_REACTION | 2.71e-08 | 17 | 166 | 6 | M39483 | |
| Pathway | WP_ESTROGEN_METABOLISM | 1.55e-07 | 22 | 166 | 6 | MM15888 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 3.72e-06 | 21 | 166 | 5 | M39631 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | CYP1A2 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 HS3ST4 FMO3 SULT1A4 | 1.32e-05 | 153 | 166 | 10 | MM15844 |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 2.83e-05 | 31 | 166 | 5 | M39476 | |
| Pathway | WP_ARYLAMINE_METABOLISM | 3.12e-05 | 6 | 166 | 3 | M39437 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | CYP1A2 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 SULT1A4 | 3.79e-05 | 107 | 166 | 8 | MM14595 |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | CYP1A2 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 SULT1A4 | 4.33e-05 | 109 | 166 | 8 | M18788 |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | CYP1A2 CYP3A5 CES2 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 FMO3 SULT1A4 | 5.67e-05 | 219 | 166 | 11 | MM14838 |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | CYP1A2 CYP3A5 CES2 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 FMO3 SULT1A4 | 5.91e-05 | 220 | 166 | 11 | M10320 |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | CYP1A2 CYP3A5 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT2B1 HS3ST4 FMO3 SULT1A4 | 6.15e-05 | 183 | 166 | 10 | M39588 |
| Pathway | REACTOME_DRUG_ADME | 8.09e-05 | 119 | 166 | 8 | MM15692 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY | 8.60e-05 | 8 | 166 | 3 | M47715 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 8.88e-05 | 39 | 166 | 5 | MM15695 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT | 1.01e-04 | 40 | 166 | 5 | M39798 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER | 1.43e-04 | 43 | 166 | 5 | M39788 | |
| Pathway | WP_RETINOL_METABOLISM | 1.60e-04 | 44 | 166 | 5 | MM15851 | |
| Pathway | WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION | 3.26e-04 | 12 | 166 | 3 | M45559 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 3.50e-04 | 29 | 166 | 4 | M45015 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 3.57e-04 | 186 | 166 | 9 | MM15994 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | CYP1A2 MOGAT1 CYP3A5 HMGCR PTPN13 PIK3CA PIK3CD ETNK1 ACSBG2 ABCD1 GPD2 GLB1L3 INPP5F ACBD6 GBA2 DDHD1 HSD17B12 LSS | 3.75e-04 | 620 | 166 | 18 | MM15193 |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 5.60e-04 | 87 | 166 | 6 | MM15600 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 5.95e-04 | 88 | 166 | 6 | M41810 | |
| Pubmed | 1.01e-13 | 11 | 215 | 7 | 10720750 | ||
| Pubmed | 1.01e-13 | 11 | 215 | 7 | 11154739 | ||
| Pubmed | Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. | 1.01e-13 | 11 | 215 | 7 | 9034160 | |
| Pubmed | Structural and chemical profiling of the human cytosolic sulfotransferases. | 5.20e-13 | 13 | 215 | 7 | 17425406 | |
| Pubmed | Ethanol sulfation by the human cytosolic sulfotransferases: a systematic analysis. | 4.30e-12 | 9 | 215 | 6 | 23207770 | |
| Pubmed | 4.30e-12 | 9 | 215 | 6 | 19548878 | ||
| Pubmed | Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. | 1.07e-11 | 10 | 215 | 6 | 11535246 | |
| Pubmed | 9.08e-10 | 18 | 215 | 6 | 20056724 | ||
| Pubmed | 1.06e-09 | 9 | 215 | 5 | 8468045 | ||
| Pubmed | 1.42e-09 | 4 | 215 | 4 | 33414449 | ||
| Pubmed | 1.42e-09 | 4 | 215 | 4 | 8943792 | ||
| Pubmed | 1.42e-09 | 4 | 215 | 4 | 8288252 | ||
| Pubmed | 1.42e-09 | 4 | 215 | 4 | 25370010 | ||
| Pubmed | 1.42e-09 | 4 | 215 | 4 | 24318996 | ||
| Pubmed | A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP. | 1.42e-09 | 4 | 215 | 4 | 12390022 | |
| Pubmed | 1.42e-09 | 4 | 215 | 4 | 8424956 | ||
| Pubmed | 7.07e-09 | 5 | 215 | 4 | 25053625 | ||
| Pubmed | 7.07e-09 | 5 | 215 | 4 | 24802129 | ||
| Pubmed | 7.07e-09 | 5 | 215 | 4 | 26169578 | ||
| Pubmed | 7.07e-09 | 5 | 215 | 4 | 11389699 | ||
| Pubmed | 7.07e-09 | 5 | 215 | 4 | 29908303 | ||
| Pubmed | 2.73e-08 | 30 | 215 | 6 | 20529763 | ||
| Pubmed | CYP1A2 CYP3A5 CES2 ABCB1 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT2B1 ABCD1 LIPA | 3.79e-08 | 193 | 215 | 11 | 19343046 | |
| Pubmed | 4.90e-08 | 7 | 215 | 4 | 12438748 | ||
| Pubmed | 4.90e-08 | 7 | 215 | 4 | 9370299 | ||
| Pubmed | Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. | 9.75e-08 | 8 | 215 | 4 | 10594240 | |
| Pubmed | 1.22e-07 | 38 | 215 | 6 | 20214802 | ||
| Pubmed | Chromosomal localization of the mouse genes encoding the ERK1 and ERK2 isoforms of MAP kinases. | 1.75e-07 | 9 | 215 | 4 | 9060415 | |
| Pubmed | 1.75e-07 | 9 | 215 | 4 | 8887328 | ||
| Pubmed | 1.75e-07 | 9 | 215 | 4 | 9177785 | ||
| Pubmed | 1.75e-07 | 9 | 215 | 4 | 9166597 | ||
| Pubmed | 2.33e-07 | 3 | 215 | 3 | 9855620 | ||
| Pubmed | In silico mechanistic profiling to probe small molecule binding to sulfotransferases. | 2.33e-07 | 3 | 215 | 3 | 24039991 | |
| Pubmed | 2.33e-07 | 3 | 215 | 3 | 16800822 | ||
| Pubmed | Identification of two human brain aryl sulfotransferase cDNAs. | 2.33e-07 | 3 | 215 | 3 | 8363592 | |
| Pubmed | 2.33e-07 | 3 | 215 | 3 | 8912648 | ||
| Pubmed | 2.33e-07 | 3 | 215 | 3 | 7961757 | ||
| Pubmed | 2.90e-07 | 10 | 215 | 4 | 7601475 | ||
| Pubmed | Localization of the murine cholecystokinin A and B receptor genes. | 4.53e-07 | 11 | 215 | 4 | 7613026 | |
| Pubmed | Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. | 4.53e-07 | 11 | 215 | 4 | 8954725 | |
| Pubmed | Identification of four chromosomal loci determining obesity in a multifactorial mouse model. | 6.76e-07 | 12 | 215 | 4 | 7706460 | |
| Pubmed | ENDOD1 CACNA2D2 RRM1 ZNF804A SULT1A2 SULT1A1 SULT1A3 GLDC CNR1 SULT1A4 CST3 HSD17B12 RESP18 | 7.32e-07 | 376 | 215 | 13 | 24154525 | |
| Pubmed | EPHB4 SOX10 UAP1 CES2 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 CUL4A DNAH10 KAT6A INPP5F LIPA SULT1A4 PAK1 KAT6B | 7.86e-07 | 730 | 215 | 18 | 34857952 | |
| Pubmed | 9.28e-07 | 4 | 215 | 3 | 32152050 | ||
| Pubmed | 9.28e-07 | 4 | 215 | 3 | 30422888 | ||
| Pubmed | 9.72e-07 | 13 | 215 | 4 | 10585447 | ||
| Pubmed | 1.84e-06 | 15 | 215 | 4 | 1741163 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK4 UAP1 MCCC1 ANKRD27 PTPN13 NF1 CEP95 SIK2 ARHGAP21 CUL4A FOXO1 ESYT1 PAK5 STK32C INPP5F MAP3K6 AASS MAP3K21 OTOG | 1.98e-06 | 861 | 215 | 19 | 36931259 |
| Pubmed | 3.29e-06 | 101 | 215 | 7 | 9872452 | ||
| Pubmed | 4.60e-06 | 6 | 215 | 3 | 19934793 | ||
| Pubmed | Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population. | 4.60e-06 | 6 | 215 | 3 | 17635176 | |
| Pubmed | Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3. | 4.60e-06 | 6 | 215 | 3 | 11524702 | |
| Pubmed | 6.37e-06 | 20 | 215 | 4 | 21072184 | ||
| Pubmed | 7.83e-06 | 21 | 215 | 4 | 32301970 | ||
| Pubmed | CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility. | 8.01e-06 | 7 | 215 | 3 | 18318428 | |
| Pubmed | Pairwise combinations of estrogen metabolism genotypes in postmenopausal breast cancer etiology. | 8.01e-06 | 7 | 215 | 3 | 17372239 | |
| Pubmed | 8.01e-06 | 7 | 215 | 3 | 20505544 | ||
| Pubmed | Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone. | 8.73e-06 | 117 | 215 | 7 | 18996102 | |
| Pubmed | EPHB4 HMGCR BRCA2 PIK3CA PIK3CD LTB4R CUL4A NPEPPS RET SLC33A1 | 9.51e-06 | 276 | 215 | 10 | 28319085 | |
| Pubmed | 1.28e-05 | 8 | 215 | 3 | 20147896 | ||
| Pubmed | ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine. | 1.28e-05 | 8 | 215 | 3 | 19593168 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ENDOD1 CACNA2D2 VPS13C DDT ITFG1 PTPN13 SMPDL3B ARID5B KATNIP CUL4A TCF7L2 OGT STXBP5L NPEPPS KAT6A STK32C UBLCP1 DNAH1 SPTBN4 PPP2R2C DIP2C LSS RIMS1 KAT6B | 1.90e-05 | 1489 | 215 | 24 | 28611215 |
| Pubmed | Prevalence of common disease-associated variants in Asian Indians. | 1.90e-05 | 9 | 215 | 3 | 18248681 | |
| Pubmed | Identification of genetic variants associated with response to statin therapy. | 1.90e-05 | 9 | 215 | 3 | 19667110 | |
| Pubmed | Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk. | 1.90e-05 | 9 | 215 | 3 | 16985250 | |
| Pubmed | 1.90e-05 | 9 | 215 | 3 | 17178267 | ||
| Pubmed | 1.90e-05 | 9 | 215 | 3 | 20182906 | ||
| Pubmed | 2.23e-05 | 27 | 215 | 4 | 20173083 | ||
| Pubmed | Irinotecan pathway genotype analysis to predict pharmacokinetics. | 2.71e-05 | 10 | 215 | 3 | 12960109 | |
| Pubmed | 2.80e-05 | 192 | 215 | 8 | 20602615 | ||
| Pubmed | 3.43e-05 | 30 | 215 | 4 | 9405660 | ||
| Pubmed | Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism. | 3.71e-05 | 11 | 215 | 3 | 20389299 | |
| Pubmed | 3.71e-05 | 11 | 215 | 3 | 19776291 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 25590378 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 35859387 | ||
| Pubmed | Active site mutations and substrate inhibition in human sulfotransferase 1A1 and 1A3. | 3.80e-05 | 2 | 215 | 2 | 14871892 | |
| Pubmed | PI3 kinase alpha and delta promote hematopoietic stem cell activation. | 3.80e-05 | 2 | 215 | 2 | 31120863 | |
| Pubmed | Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B. | 3.80e-05 | 2 | 215 | 2 | 12185535 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 26421491 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 38962329 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 25819444 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 11207031 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 12761191 | ||
| Pubmed | Genetic variations in ABCB1 and CYP3A5 as well as sex influence quinine disposition among Ugandans. | 3.80e-05 | 2 | 215 | 2 | 20357698 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 23364483 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 15167702 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 21188463 | ||
| Pubmed | CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation. | 3.80e-05 | 2 | 215 | 2 | 15116055 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 15226679 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 26856709 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 29991328 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 12486171 | ||
| Pubmed | Social learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-activated kinase. | 3.80e-05 | 2 | 215 | 2 | 25242307 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 18936931 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 25014506 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 28736028 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 19289993 | ||
| Pubmed | FOXO1 and TCF7L2 genes involved in metastasis and poor prognosis in clear cell renal cell carcinoma. | 3.80e-05 | 2 | 215 | 2 | 20095040 | |
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 28330783 | ||
| Pubmed | 3.80e-05 | 2 | 215 | 2 | 25521359 | ||
| Interaction | SULT1A3 interactions | 2.56e-09 | 24 | 200 | 7 | int:SULT1A3 | |
| Interaction | SULT1B1 interactions | 6.39e-07 | 8 | 200 | 4 | int:SULT1B1 | |
| Interaction | SULT1C2 interactions | 9.51e-07 | 19 | 200 | 5 | int:SULT1C2 | |
| Interaction | SULT4A1 interactions | 3.34e-06 | 24 | 200 | 5 | int:SULT4A1 | |
| Interaction | SULT1A4 interactions | 8.72e-06 | 14 | 200 | 4 | int:SULT1A4 | |
| Interaction | SULT2B1 interactions | 3.12e-05 | 61 | 200 | 6 | int:SULT2B1 | |
| Interaction | SULT1A2 interactions | 3.25e-05 | 19 | 200 | 4 | int:SULT1A2 | |
| Interaction | SMPDL3B interactions | 4.01e-05 | 39 | 200 | 5 | int:SMPDL3B | |
| Cytoband | 16p12.1 | 5.48e-06 | 25 | 215 | 4 | 16p12.1 | |
| GeneFamily | Sulfotransferases, cytosolic | 8.84e-12 | 14 | 153 | 7 | 762 | |
| GeneFamily | Olfactory receptors, family 6 | 4.38e-06 | 51 | 153 | 6 | 153 | |
| GeneFamily | Dyneins, axonemal | 3.70e-04 | 17 | 153 | 3 | 536 | |
| GeneFamily | Fibronectin type III domain containing | 4.29e-04 | 160 | 153 | 7 | 555 | |
| GeneFamily | Protein phosphatase 2 modulatory subunits | 7.00e-04 | 5 | 153 | 2 | 1265 | |
| GeneFamily | Lipases|Arylacetamide deacetylase family | 8.13e-04 | 22 | 153 | 3 | 464 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 1.93e-03 | 8 | 153 | 2 | 831 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | DOCK4 ENDOD1 MTSS1 PTGER4 ABCB1 EHD4 CLIC5 PIK3CA ARID5B MED12L PLAT GPD2 ATG10 ARID4A NSF UBLCP1 LIPA RDH16 ARVCF MYOM2 ZNF91 SLC33A1 | 3.78e-06 | 888 | 213 | 22 | MM1018 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | DOCK4 ENDOD1 MTSS1 PTGER4 ABCB1 EHD4 CLIC5 PIK3CA ARID5B MED12L PLAT GPD2 ATG10 ARID4A NSF UBLCP1 LIPA RDH16 ARVCF MYOM2 SLC33A1 | 7.13e-06 | 854 | 213 | 21 | M1533 |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN | 1.93e-05 | 68 | 213 | 6 | MM770 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 ZNF804A RYK HIRA FAT1 PTPN13 BRCA2 ARID5B NUP160 TCF7L2 OGT ARID4A NPEPPS KAT6A INPP5F ZDHHC17 CBFB NBAS MAP4K5 KAT6B | 2.47e-05 | 856 | 213 | 20 | M4500 |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN | 3.87e-05 | 199 | 213 | 9 | M9418 | |
| Coexpression | VERNOCHET_ADIPOGENESIS | 3.97e-05 | 24 | 213 | 4 | MM1317 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN | 4.02e-05 | 200 | 213 | 9 | M6662 | |
| Coexpression | HASEGAWA_TUMORIGENESIS_BY_RET_C634R | 4.29e-05 | 9 | 213 | 3 | M1334 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 4.52e-05 | 157 | 213 | 8 | MM1099 | |
| Coexpression | LE_EGR2_TARGETS_DN | 4.94e-05 | 117 | 213 | 7 | MM1139 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 FAT1 PCDH11X USH2A DNAH9 STAB2 DNAH10 STXBP5L DNAH1 HMCN1 MYOM2 UNC80 OTOG | 5.88e-12 | 184 | 213 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 FAT1 PCDH11X USH2A DNAH9 STAB2 DNAH10 STXBP5L DNAH1 HMCN1 MYOM2 UNC80 OTOG | 5.88e-12 | 184 | 213 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 FAT1 PCDH11X USH2A DNAH9 STAB2 DNAH10 STXBP5L DNAH1 HMCN1 MYOM2 UNC80 OTOG | 5.88e-12 | 184 | 213 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | ARHGAP42 EPHB4 PCDH11X ETNK1 COL14A1 NTAQ1 KAT6A ARVCF RIMS1 | 1.12e-07 | 166 | 213 | 9 | b64ab3d13b76bba3c305ebbfc96f983cd6ca30c9 |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.69e-07 | 191 | 213 | 9 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.55e-07 | 143 | 213 | 8 | 138033ff447a61a1bc289b21db82151dcc6a4c7e | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-06 | 160 | 213 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-06 | 160 | 213 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-06 | 166 | 213 | 8 | bb93db4613c067c56614ab1ca39e73ee46484387 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-MAIT|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-06 | 166 | 213 | 8 | c1f17a028bb27b8f202bcfffa7de7373b1cdd990 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 2.00e-06 | 174 | 213 | 8 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.57e-06 | 180 | 213 | 8 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 3.15e-06 | 185 | 213 | 8 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.41e-06 | 187 | 213 | 8 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.84e-06 | 190 | 213 | 8 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.99e-06 | 191 | 213 | 8 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.99e-06 | 191 | 213 | 8 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.99e-06 | 191 | 213 | 8 | fcdf3a747038e346a467eae8b7c293592658b53f | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.15e-06 | 192 | 213 | 8 | 1d0d6fb89a2b941b7caab2f1f07d6bd5433a11e7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.31e-06 | 193 | 213 | 8 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | CTRL-Myeloid-Monocyte_Macrophage|Myeloid / Disease state, Lineage and Cell class | 4.48e-06 | 194 | 213 | 8 | 73459ee062ae1f1a3bb9719dc0b89aae10600e22 | |
| ToppCell | CTRL-Myeloid-Monocyte_Macrophage|CTRL / Disease state, Lineage and Cell class | 4.48e-06 | 194 | 213 | 8 | 927480f56cccd3940b689f3c40ee132fe3e63745 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-MAIT|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.65e-06 | 195 | 213 | 8 | caa3669739974b63470f7e557df96e8d3844dd84 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.65e-06 | 195 | 213 | 8 | bc5728e9df0b15adec50a7c840ce9f2775135087 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Epithelial-Hepatocyte_(Midlobular)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-06 | 139 | 213 | 7 | e363c69b58cff8571ca75b91a3d052f9cbccac27 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.20e-06 | 198 | 213 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.20e-06 | 198 | 213 | 8 | 4a481e1edb80b950c823ed926842cd5132cfb27f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-05 | 162 | 213 | 7 | bc63a96ad3ba0b3433e3679d7a005f47709ff384 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-05 | 162 | 213 | 7 | 922ecea81063095b8dd9ac9f9792bf551edbb848 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.43e-05 | 164 | 213 | 7 | be49af6335f2505065cde2cb9800e4a5516811b1 | |
| ToppCell | NS-critical-d_0-4-Epithelial-unknown_epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.55e-05 | 166 | 213 | 7 | dd02bbe4af609c6348dc92417254f4740f2900a8 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-05 | 169 | 213 | 7 | 2456b3e7776e8a2214972be1b4d66a3ca5480ae0 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 169 | 213 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-05 | 171 | 213 | 7 | 0de81d12a8000f2c59cdb214e67dc526d18098fe | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-05 | 171 | 213 | 7 | 0597339618fb4d416d55c538eceb353218a55002 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-Alox5+_Lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 174 | 213 | 7 | a8bd1fa08bf061a627529a38e5a23a68b6d80697 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 174 | 213 | 7 | 7f8f6a15a823809effd37c1a5b09ef19b6d67755 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-05 | 174 | 213 | 7 | 7b318796728001c17b4043d2b033330c7be40c78 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 175 | 213 | 7 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 176 | 213 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-05 | 176 | 213 | 7 | c2c4306476989bc2fb30dab00250ef7915842f13 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-mature_NK_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 177 | 213 | 7 | 93379bfd7484812bb45aa27c0324a75be9641685 | |
| ToppCell | 3'_v3-lymph-node_spleen-Mast-Mast_cell_lympho|lymph-node_spleen / Manually curated celltypes from each tissue | 2.34e-05 | 177 | 213 | 7 | 53040dbeb18574a48e352e4bce252c7c3018762c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.52e-05 | 179 | 213 | 7 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-05 | 181 | 213 | 7 | 89c551de26de047c316c91ac1d97bdf728a33d9e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.80e-05 | 182 | 213 | 7 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.80e-05 | 182 | 213 | 7 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-Treg|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.90e-05 | 183 | 213 | 7 | f478dfa231fc1b12ead0183cc9d22077cdf43d1f | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.00e-05 | 184 | 213 | 7 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | Endothelial-E|World / shred on cell class and cell subclass (v4) | 3.00e-05 | 184 | 213 | 7 | b4c561924c508536fd2112e91e32176b95fdf63a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 185 | 213 | 7 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.11e-05 | 185 | 213 | 7 | 29d7ddcb9a2e45f76cd5611f7c52b6df689effd3 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.11e-05 | 185 | 213 | 7 | 780bdb63ef913a09930063286011c9108381d3a9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.11e-05 | 185 | 213 | 7 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM4|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.11e-05 | 185 | 213 | 7 | 274b8acccdfe434d14af4cb32fb615c06ec98435 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.11e-05 | 185 | 213 | 7 | b640d9ed6a1e6aa595053065bb992efc0402353e | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.11e-05 | 185 | 213 | 7 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 3.22e-05 | 186 | 213 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 186 | 213 | 7 | d6c8ce2a32c218dcc63d861cc247152430ed3c8c | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_T-T_NK-NK_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.22e-05 | 186 | 213 | 7 | b099cb0902e9afb11218d70407d3cab212343c6d | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 186 | 213 | 7 | cc94e0c5d1665d2ea2bb871ad79d8e1ec2249fb5 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.22e-05 | 186 | 213 | 7 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.33e-05 | 187 | 213 | 7 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-05 | 187 | 213 | 7 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.44e-05 | 188 | 213 | 7 | 5eb107122064f0a99dfd445cc87d3766f7257216 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.44e-05 | 188 | 213 | 7 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Trm_Th1/Th17|lymph-node_spleen / Manually curated celltypes from each tissue | 3.44e-05 | 188 | 213 | 7 | a20521198c6db17589535fb439533329582c9dd2 | |
| ToppCell | Endothelial-Endothelial-E|Endothelial / shred on cell class and cell subclass (v4) | 3.44e-05 | 188 | 213 | 7 | 2777eb7689b271c199021fe7d9db88ccebff14de | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.56e-05 | 189 | 213 | 7 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-05 | 189 | 213 | 7 | e4efbb0733b382f4c855f6653dcddf36e0f8df28 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.56e-05 | 189 | 213 | 7 | 637f26503e4bd7b4e5642ec1a722ffabcda4fac7 | |
| ToppCell | ASK452-Immune-T_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.56e-05 | 189 | 213 | 7 | f5dc500f77f04a110dd4a65cf4c03068a495dbdb | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.56e-05 | 189 | 213 | 7 | 2424e4dc9e8c7f5b3b31272405c6c1d4c8af6d9e | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.68e-05 | 190 | 213 | 7 | 9b0ad888eb20acc011904d8593bc32bdef18d050 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-Th17|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.81e-05 | 191 | 213 | 7 | b3ed4797a7a9810cf3507e0d0f23f45c35bd8ba2 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.94e-05 | 192 | 213 | 7 | c157981b9a179925edcaabc0cb3b8805f0929004 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.94e-05 | 192 | 213 | 7 | cd4c9b9ab17a779c154264f7459020f51e528ba5 | |
| ToppCell | NS-control-d_0-4-Lymphoid-Treg|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.94e-05 | 192 | 213 | 7 | ef252dd9df161f665f53c047c0514381f80d6683 | |
| ToppCell | Control-Myeloid-MoAM4|Control / Disease group,lineage and cell class （2021.01.30） | 3.94e-05 | 192 | 213 | 7 | 1da7c303a2e36af4a9d8ec30a11380d9b1897922 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-05 | 192 | 213 | 7 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.07e-05 | 193 | 213 | 7 | 947200ef6c3a2e35ad7e6b4af29d92384bdf73f5 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.07e-05 | 193 | 213 | 7 | afdf92ecace145407d57192dde5d0dac0bc37ee9 | |
| ToppCell | moderate-Lymphoid-CTL|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.07e-05 | 193 | 213 | 7 | 3fce0807631811da1cff5ca9db23ff1ad36020e7 | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.34e-05 | 195 | 213 | 7 | ed052c6d3dc104b02e34b645abfdee477af050c6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.34e-05 | 195 | 213 | 7 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.34e-05 | 195 | 213 | 7 | c5d2d9f12fd893331c9de261af30607d845d4f6a | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-05 | 196 | 213 | 7 | 61bee32ca299219f31a30b57124e44e85b798e9f | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.49e-05 | 196 | 213 | 7 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.63e-05 | 197 | 213 | 7 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.63e-05 | 197 | 213 | 7 | 5c88a97e8e23a5cd61885acbe1ef339ae6a1e35a | |
| ToppCell | Enterocyte|World / shred on cell type and cluster | 4.63e-05 | 197 | 213 | 7 | 1dd980fd066aef21694395a4b69df938501d9631 | |
| ToppCell | mLN-(1)_T_cell-(13)_Th17|mLN / shred on region, Cell_type, and subtype | 4.78e-05 | 198 | 213 | 7 | c575e9aeee4e034e8c4d171fe754403652343731 | |
| ToppCell | mLN-T_cell-Th17|T_cell / Region, Cell class and subclass | 4.78e-05 | 198 | 213 | 7 | efdc9515dd9fb20ef9c8ddc106d88cbdde7d6ea2 | |
| ToppCell | mLN-T_cell-Th17|mLN / Region, Cell class and subclass | 4.78e-05 | 198 | 213 | 7 | 04905f62941b193864704a10ad692faf777fa51d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.78e-05 | 198 | 213 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.78e-05 | 198 | 213 | 7 | 484d16aaa601a1e11b871b0475dd01a2de1a29ce | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.78e-05 | 198 | 213 | 7 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.78e-05 | 198 | 213 | 7 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Transverse-T_cell-Th17|Transverse / Region, Cell class and subclass | 4.94e-05 | 199 | 213 | 7 | 640989e048b08d66c5020e032a61ef05f3831034 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 4.94e-05 | 199 | 213 | 7 | f30e9d3d095a1e12d759debe27540aad32861db6 | |
| Drug | MeA alpha C | 8.89e-10 | 22 | 214 | 7 | CID000062244 | |
| Drug | DCNP | 2.04e-08 | 33 | 214 | 7 | CID000012066 | |
| Drug | A21250 | RRM1 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 HS3ST4 SULT1A4 P2RY1 | 5.78e-08 | 105 | 214 | 10 | CID000000990 |
| Drug | AalphaC | 7.51e-08 | 24 | 214 | 6 | CID000062805 | |
| Drug | 4-hydroxyestrone | CYP1A2 CYP3A5 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT1A4 | 7.85e-08 | 59 | 214 | 8 | CID000018418 |
| Drug | EM-139 | 8.47e-08 | 13 | 214 | 5 | CID000131427 | |
| Drug | minoxidil sulphate | 9.81e-08 | 25 | 214 | 6 | CID000004202 | |
| Drug | glycolithocholic acid | 1.26e-07 | 26 | 214 | 6 | CID000115245 | |
| Drug | deoxoestrone | 1.31e-07 | 14 | 214 | 5 | CID000005888 | |
| Drug | cyclobenzaprine | 1.95e-07 | 15 | 214 | 5 | CID000002895 | |
| Drug | arylsulfate | 1.95e-07 | 15 | 214 | 5 | CID000074426 | |
| Drug | Glu-P-2 | 2.55e-07 | 29 | 214 | 6 | CID000049970 | |
| Drug | luciferyl sulfate | 2.60e-07 | 7 | 214 | 4 | CID011953812 | |
| Drug | Phosphoadenosine Phosphosulfate | 2.60e-07 | 7 | 214 | 4 | ctd:D010724 | |
| Drug | dopamine-4-O-sulfate | 2.60e-07 | 7 | 214 | 4 | CID000123932 | |
| Drug | 2-naphthylsulfate | 2.60e-07 | 7 | 214 | 4 | CID000074428 | |
| Drug | 2-iodo-4-azidophenol | 2.60e-07 | 7 | 214 | 4 | CID003035977 | |
| Drug | N-hydroxy-2-acetylaminofluorene | 3.12e-07 | 48 | 214 | 7 | CID000005896 | |
| Drug | 3,3'-T2 | 3.16e-07 | 30 | 214 | 6 | CID000065559 | |
| Drug | 1-naphthol | CYP1A2 CYP3A5 CES2 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT1A4 | 3.69e-07 | 98 | 214 | 9 | CID000007005 |
| Drug | acetaminophen sulfate | 3.89e-07 | 31 | 214 | 6 | CID000083939 | |
| Drug | benzilic acid | 3.95e-07 | 17 | 214 | 5 | CID000006463 | |
| Drug | dopamine 3-O-sulfate | 5.16e-07 | 8 | 214 | 4 | CID000122136 | |
| Drug | 6-anilino-2-thiouracil | 5.16e-07 | 8 | 214 | 4 | CID003037707 | |
| Drug | 2-iodophenol | 5.16e-07 | 8 | 214 | 4 | CID000010784 | |
| Drug | minoxidil | 7.15e-07 | 54 | 214 | 7 | CID000004201 | |
| Drug | androstenediol | 7.15e-07 | 54 | 214 | 7 | CID000010634 | |
| Drug | ITdU | CYP3A5 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 PIK3CA PIK3CD PLAT ABCD1 GPD2 SULT1A4 HSD17B12 | 7.57e-07 | 292 | 214 | 14 | CID000000076 |
| Drug | 4-hydroxyestradiol | CYP1A2 CYP3A5 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT1A4 | 7.86e-07 | 79 | 214 | 8 | CID000001743 |
| Drug | Adenosine-3'-5'-Diphosphate | 9.22e-07 | 9 | 214 | 4 | DB01812 | |
| Drug | 4-nitrophenol | CYP1A2 CYP3A5 CES2 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT2B1 GBA2 SULT1A4 | 9.76e-07 | 177 | 214 | 11 | CID000000980 |
| Drug | reverse T3 | 1.05e-06 | 82 | 214 | 8 | CID000022069 | |
| Drug | NSC36919 | 1.18e-06 | 58 | 214 | 7 | CID000235496 | |
| Drug | N-hydroxy-2-aminofluorene | 1.26e-06 | 21 | 214 | 5 | CID000005895 | |
| Drug | AABSSN | 1.62e-06 | 22 | 214 | 5 | CID005464134 | |
| Drug | 3-OHBaP | 2.08e-06 | 63 | 214 | 7 | CID000025890 | |
| Drug | 4-nonylphenol | 2.32e-06 | 64 | 214 | 7 | CID000001752 | |
| Drug | 2-amino-3-methyl-9H-pyrido(2,3-b)indole | 2.38e-06 | 11 | 214 | 4 | ctd:C017821 | |
| Drug | S-benzyl-L-cysteine | 2.57e-06 | 24 | 214 | 5 | CID000076454 | |
| Drug | 2-naphthol | CYP1A2 CYP3A5 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT1A4 | 2.74e-06 | 93 | 214 | 8 | CID000008663 |
| Drug | Woodward's reagent K | 2.93e-06 | 43 | 214 | 6 | CID000077804 | |
| Drug | 2-hydroxyestradiol | 3.19e-06 | 25 | 214 | 5 | ctd:C001390 | |
| Drug | flunixin meglumine | 3.25e-06 | 4 | 214 | 3 | ctd:C014558 | |
| Drug | NDPS | 3.86e-06 | 45 | 214 | 6 | CID000090363 | |
| Drug | adenosine 3'-5'-diphosphate | SULT1E1 SULT1A2 SULT1A1 SULT1A3 SULT2B1 HS3ST4 SULT1A4 P2RY1 | 4.07e-06 | 98 | 214 | 8 | CID000000073 |
| Drug | Pyrethroids | 4.69e-06 | 71 | 214 | 7 | CID000005053 | |
| Drug | 1 C2 | CYP3A5 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT1A3 SULT1A4 AIFM1 | 4.74e-06 | 100 | 214 | 8 | CID005327152 |
| Drug | 3-methyloxindole | 5.08e-06 | 13 | 214 | 4 | CID000150923 | |
| Drug | sulfamethazine | 5.67e-06 | 48 | 214 | 6 | CID000005327 | |
| Drug | catechol | CYP1A2 CYP3A5 RRM1 CA10 ABCB1 SULT1A2 SULT1A1 SULT1A3 TF SULT1A4 ARVCF AIFM1 | 6.22e-06 | 257 | 214 | 12 | CID000000289 |
| Drug | 7-hydroxycoumarin | 6.78e-06 | 75 | 214 | 7 | CID005281426 | |
| Drug | naphthalenemethanol | 7.06e-06 | 14 | 214 | 4 | CID000020908 | |
| Drug | AC1OAI2Y | 8.08e-06 | 5 | 214 | 3 | CID006805031 | |
| Drug | D.E.T | 8.24e-06 | 30 | 214 | 5 | CID000006090 | |
| Drug | 9-hydroxybenzo(a)pyrene | 1.02e-05 | 53 | 214 | 6 | CID000028598 | |
| Drug | acetaminophen | CYP1A2 CYP3A5 RRM1 ABCB1 SULT1A2 SULT1A1 SULT1A3 THG1L CCR6 SULT1A4 AIFM1 AASS | 1.02e-05 | 270 | 214 | 12 | CID000001983 |
| Drug | AC1L3JHX | 1.03e-05 | 146 | 214 | 9 | CID000090206 | |
| Drug | dodecyl gallate | 1.26e-05 | 16 | 214 | 4 | CID000014425 | |
| Drug | A-44 | 1.26e-05 | 16 | 214 | 4 | CID000120353 | |
| Drug | AC1Q6OQF | 1.27e-05 | 55 | 214 | 6 | CID000009685 | |
| Drug | MeIQx | 1.27e-05 | 55 | 214 | 6 | CID000062275 | |
| Drug | 2,4,5-trichlorophenol | 1.41e-05 | 56 | 214 | 6 | CID000007271 | |
| Drug | prazosin hydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.46e-05 | 192 | 214 | 10 | 942_DN | |
| Drug | Ajmaline [4360-12-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.82e-05 | 197 | 214 | 10 | 2899_DN | |
| Drug | AC1O4QIW | 1.91e-05 | 59 | 214 | 6 | CID006398478 | |
| Drug | Fenbendazole [43210-67-9]; Up 200; 13.4uM; PC3; HT_HG-U133A | CYP1A2 CYP3A5 MTSS1 SULT1E1 NF1 CLIC5 PTPRH COL14A1 LTB4R TF | 1.99e-05 | 199 | 214 | 10 | 3805_UP |
| Drug | L 742694 | 2.39e-05 | 37 | 214 | 5 | ctd:C099406 | |
| Drug | mefenamic acid | 2.39e-05 | 37 | 214 | 5 | CID000004044 | |
| Drug | galangin | 2.39e-05 | 37 | 214 | 5 | CID005281616 | |
| Drug | estrone sulfate | CYP1A2 ABCB1 SULT1E1 SULT1A2 SULT1A1 SULT1A3 CCDC80 SULT1A4 HSD17B12 | 2.48e-05 | 163 | 214 | 9 | CID000000699 |
| Drug | p-nitroanisole | 2.62e-05 | 92 | 214 | 7 | CID000007485 | |
| Drug | AC1Q6OHG | 2.63e-05 | 19 | 214 | 4 | CID000115063 | |
| Drug | pedunculagin | 2.63e-05 | 19 | 214 | 4 | CID000442688 | |
| Drug | benzydamine N-oxide | 2.79e-05 | 7 | 214 | 3 | CID000065465 | |
| Drug | 2-hydroxyestradiol | 2.79e-05 | 63 | 214 | 6 | CID000009684 | |
| Drug | AC1O3UYX | 2.79e-05 | 63 | 214 | 6 | CID006338583 | |
| Drug | chlorpyrifos oxon | 3.06e-05 | 64 | 214 | 6 | CID000021804 | |
| Drug | n-octylamine | 3.11e-05 | 39 | 214 | 5 | CID000008143 | |
| Drug | estrone-d4 | CYP1A2 CYP3A5 ABCB1 SULT1E1 SULT1A2 SULT1A1 SULT1A3 SULT1A4 HSD17B12 | 3.15e-05 | 168 | 214 | 9 | CID000000698 |
| Drug | PLP-Glu | 3.27e-05 | 20 | 214 | 4 | CID000444293 | |
| Drug | 4-methylumbelliferone | CYP1A2 CYP3A5 SULT1E1 SULT1A2 SULT1B1 SULT1A1 SULT2B1 HS3ST4 | 3.63e-05 | 132 | 214 | 8 | CID003364573 |
| Drug | 17alpha-estradiol | EPHB4 CYP1A2 CYP3A5 HMGCR RRM1 FOXA1 PTGER4 CES2 SULT1E1 SULT1A2 SULT1B1 PTPN13 SULT1A1 SULT1A3 SULT2B1 PIK3CA PIK3CD PLAT GPD2 CHRNA6 CLCA4 HTR1A TF PPP2R2C SULT1A4 AIFM1 HSD17B12 TUBD1 | 3.83e-05 | 1303 | 214 | 28 | CID000000450 |
| Drug | d-equilenin | 3.98e-05 | 41 | 214 | 5 | CID000010597 | |
| Drug | furafylline | 3.98e-05 | 41 | 214 | 5 | CID000003433 | |
| Drug | 4-methoxyestradiol | 4.01e-05 | 21 | 214 | 4 | CID000068578 | |
| Drug | 2-amino-1-methyl-6-(4-hydroxyphenyl)imidazo(4,5-b)pyridine | 4.43e-05 | 8 | 214 | 3 | ctd:C077584 | |
| Drug | 3-methylmargaric acid | 4.43e-05 | 8 | 214 | 3 | CID000173764 | |
| Drug | 1-hydroxymethylpyrene | 4.43e-05 | 8 | 214 | 3 | ctd:C065833 | |
| Drug | N-hydroxy-4-aminobiphenyl | 4.43e-05 | 8 | 214 | 3 | ctd:C014593 | |
| Drug | R7 1 | 4.43e-05 | 8 | 214 | 3 | CID000001949 | |
| Drug | delavirdine | 4.49e-05 | 42 | 214 | 5 | CID000005625 | |
| Drug | naringenin | 4.49e-05 | 136 | 214 | 8 | CID000000932 | |
| Drug | N-methyl-DL-aspartic acid | SOX10 CACNA2D2 PTGER4 ITIH4 FAT1 SULT2B1 PIK3CA PIK3CD PLAT CNR1 CHRNA6 HTR1A NSF ZDHHC17 GRM8 AIFM1 HSD17B12 RIMS1 | 5.08e-05 | 655 | 214 | 18 | CID000004376 |
| Drug | 3-hydroxyandrostan-17-one | 5.10e-05 | 102 | 214 | 7 | CID000000225 | |
| Drug | N-acetylglucosaminolactone | 5.11e-05 | 70 | 214 | 6 | CID000087901 | |
| Drug | deltoin | 5.53e-05 | 71 | 214 | 6 | CID000021908 | |
| Drug | sulfaphenazole | 5.64e-05 | 44 | 214 | 5 | CID000005335 | |
| Drug | taselin | 5.84e-05 | 23 | 214 | 4 | CID000023846 | |
| Drug | aniline | 6.10e-05 | 142 | 214 | 8 | CID000006115 | |
| Drug | 4-nitrophenol | 6.30e-05 | 45 | 214 | 5 | ctd:C024836 | |
| Disease | breast cancer (is_implicated_in) | CYP1A2 PSEN2 FOXA1 SULT1E1 PTPN13 SULT1A1 BRCA2 PIK3CA TCF7L2 PAK1 KAT6B | 8.06e-09 | 150 | 203 | 11 | DOID:1612 (is_implicated_in) |
| Disease | Schizophrenia | MAG DOCK4 SOX10 CYP1A2 PSEN2 CYP3A5 ABCA13 ZNF804A ABCB1 NRXN3 PIK3CA PLAT MED12 CNR1 TCF7L2 HTR1A GRM8 TF ARVCF GABBR1 | 3.43e-06 | 883 | 203 | 20 | C0036341 |
| Disease | endometrial cancer (is_implicated_in) | 4.65e-06 | 36 | 203 | 5 | DOID:1380 (is_implicated_in) | |
| Disease | Drug-Induced Liver Disease | CYP1A2 MCCC1 ABCB1 SULT1E1 SULT2B1 COL14A1 PLAT FMO3 CCDC80 TF TMEM38B AIFM1 AASS | 5.07e-06 | 404 | 203 | 13 | C0860207 |
| Disease | Chemical and Drug Induced Liver Injury | CYP1A2 MCCC1 ABCB1 SULT1E1 SULT2B1 COL14A1 PLAT FMO3 CCDC80 TF TMEM38B AIFM1 AASS | 5.07e-06 | 404 | 203 | 13 | C4277682 |
| Disease | Drug-Induced Acute Liver Injury | CYP1A2 MCCC1 ABCB1 SULT1E1 SULT2B1 COL14A1 PLAT FMO3 CCDC80 TF TMEM38B AIFM1 AASS | 5.07e-06 | 404 | 203 | 13 | C3658290 |
| Disease | Hepatitis, Toxic | CYP1A2 MCCC1 ABCB1 SULT1E1 SULT2B1 COL14A1 PLAT FMO3 CCDC80 TF TMEM38B AIFM1 AASS | 5.07e-06 | 404 | 203 | 13 | C0019193 |
| Disease | Chemically-Induced Liver Toxicity | CYP1A2 MCCC1 ABCB1 SULT1E1 SULT2B1 COL14A1 PLAT FMO3 CCDC80 TF TMEM38B AIFM1 AASS | 5.07e-06 | 404 | 203 | 13 | C4279912 |
| Disease | Hepatitis, Drug-Induced | CYP1A2 MCCC1 ABCB1 SULT1E1 SULT2B1 COL14A1 PLAT FMO3 CCDC80 TF TMEM38B AIFM1 AASS | 5.07e-06 | 404 | 203 | 13 | C1262760 |
| Disease | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | 6.32e-06 | 6 | 203 | 3 | C3888239 | |
| Disease | Cutaneous Melanoma | 8.99e-06 | 41 | 203 | 5 | C0151779 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.43e-05 | 45 | 203 | 5 | DOID:3748 (is_implicated_in) | |
| Disease | Adverse reaction to drug | 2.56e-05 | 84 | 203 | 6 | C0041755 | |
| Disease | Drug toxicity | 2.56e-05 | 84 | 203 | 6 | C0013221 | |
| Disease | Schizophrenia and related disorders | 2.61e-05 | 9 | 203 | 3 | C0809983 | |
| Disease | Bipolar Disorder | PSEN2 ABCA13 ZNF804A ITIH4 RACK1 BRCA2 CNR1 CHRNA6 TCF7L2 HTR1A PPP2R2C PTPA RIMS1 | 2.92e-05 | 477 | 203 | 13 | C0005586 |
| Disease | Colorectal Carcinoma | CYP1A2 CACUL1 ABCA13 MCF2L2 ZNF804A ABCB1 FAT1 NF1 SULT2B1 PIK3CA PCDH11X TCF7L2 STK32C RET DIP2C SLC33A1 | 3.14e-05 | 702 | 203 | 16 | C0009402 |
| Disease | S-methylcysteine measurement | 4.71e-05 | 2 | 203 | 2 | EFO_0800054 | |
| Disease | coronary artery disease | ARHGAP42 CYP1A2 HMGCR SPATA2 ITIH4 HIRA RPL7L1 STXBP2 CLIC5 SIK2 NUP160 ARHGAP21 TCF7L2 DHX58 DNAH10 ARID4A LIPA ARVCF HSD17B12 OR52B6 GABBR1 | 8.29e-05 | 1194 | 203 | 21 | EFO_0001645 |
| Disease | Colorectal Neoplasms | 1.38e-04 | 277 | 203 | 9 | C0009404 | |
| Disease | Schizoaffective disorder-bipolar type | 1.68e-04 | 16 | 203 | 3 | EFO_0009965 | |
| Disease | colorectal cancer (is_implicated_in) | 1.96e-04 | 121 | 203 | 6 | DOID:9256 (is_implicated_in) | |
| Disease | Adrenocortical carcinoma | 2.43e-04 | 18 | 203 | 3 | C0206686 | |
| Disease | multiple sclerosis symptom measurement | 2.83e-04 | 46 | 203 | 4 | EFO_0803536 | |
| Disease | end stage renal disease (implicated_via_orthology) | 3.35e-04 | 20 | 203 | 3 | DOID:783 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of prostate | CYP3A5 FOXA1 SULT1E1 SULT1A1 BRCA2 SULT2B1 PIK3CA PIK3CD MED12 FOXO1 STAB2 ARID4A KAT6A | 3.68e-04 | 616 | 203 | 13 | C0376358 |
| Disease | Prostatic Neoplasms | CYP3A5 FOXA1 SULT1E1 SULT1A1 BRCA2 SULT2B1 PIK3CA PIK3CD MED12 FOXO1 STAB2 ARID4A KAT6A | 3.68e-04 | 616 | 203 | 13 | C0033578 |
| Disease | Vertigo | 4.14e-04 | 139 | 203 | 6 | HP_0002321 | |
| Disease | fasting blood glucose measurement, glucose tolerance test, fasting blood insulin measurement | 4.65e-04 | 5 | 203 | 2 | EFO_0004307, EFO_0004465, EFO_0004466 | |
| Disease | Q Fever | 4.65e-04 | 5 | 203 | 2 | C0034362 | |
| Disease | intermediate coronary syndrome (is_implicated_in) | 4.65e-04 | 5 | 203 | 2 | DOID:8805 (is_implicated_in) | |
| Disease | X-17357 measurement | 4.65e-04 | 5 | 203 | 2 | EFO_0800777 | |
| Disease | Coxiella burnetii Infection | 4.65e-04 | 5 | 203 | 2 | C2973787 | |
| Disease | Acute Q fever | 4.65e-04 | 5 | 203 | 2 | C0519066 | |
| Disease | Chronic Q Fever | 4.65e-04 | 5 | 203 | 2 | C1443892 | |
| Disease | Malignant neoplasm of breast | EPHB4 MCF2L2 FOXA1 STAT4 ABCB1 NF1 SULT1A1 BRCA2 PIK3CA DNAH9 MED12 ATG10 CBFB MAP3K6 UBLCP1 PAK1 DIP2C KAT6B | 4.80e-04 | 1074 | 203 | 18 | C0006142 |
| Disease | Diffuse Large B-Cell Lymphoma | 5.64e-04 | 55 | 203 | 4 | C0079744 | |
| Disease | Alcoholic Intoxication, Chronic | 5.66e-04 | 268 | 203 | 8 | C0001973 | |
| Disease | adverse effect, response to xenobiotic stimulus | 7.36e-04 | 59 | 203 | 4 | EFO_0009658, GO_0009410 | |
| Disease | obesity (implicated_via_orthology) | 7.53e-04 | 215 | 203 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | response to cranial radiation therapy, short-term memory | 7.85e-04 | 60 | 203 | 4 | EFO_0004335, EFO_0010950 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 7.86e-04 | 157 | 203 | 6 | DOID:224 (biomarker_via_orthology) | |
| Disease | glucose tolerance test | 8.31e-04 | 27 | 203 | 3 | EFO_0004307 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 8.35e-04 | 61 | 203 | 4 | C1961102 | |
| Disease | adrenoleukodystrophy (implicated_via_orthology) | 9.67e-04 | 7 | 203 | 2 | DOID:10588 (implicated_via_orthology) | |
| Disease | electrodermal activity measurement, skin conductance response amplitude | 9.67e-04 | 7 | 203 | 2 | EFO_0006866, EFO_0006868 | |
| Disease | Disease Exacerbation | 1.02e-03 | 165 | 203 | 6 | C0235874 | |
| Disease | Neurotoxicity Syndromes | 1.03e-03 | 29 | 203 | 3 | C0235032 | |
| Disease | Encephalopathy, Toxic | 1.03e-03 | 29 | 203 | 3 | C0149504 | |
| Disease | Toxic Encephalitis | 1.03e-03 | 29 | 203 | 3 | C0154659 | |
| Disease | obsolete_red blood cell distribution width | ARHGAP42 MAG RRM1 ANKRD27 ABCB1 ITFG1 PTPRH THG1L ARHGAP21 CUL4A OGT SUN1 NOL9 CBFB GBA2 TF PTPA LIPA MAP4K5 TUBD1 | 1.06e-03 | 1347 | 203 | 20 | EFO_0005192 |
| Disease | obstructive sleep apnea | 1.12e-03 | 66 | 203 | 4 | EFO_0003918 | |
| Disease | QRS duration | 1.12e-03 | 298 | 203 | 8 | EFO_0005055 | |
| Disease | free androgen index | 1.20e-03 | 374 | 203 | 9 | EFO_0007005 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 1.22e-03 | 171 | 203 | 6 | DOID:9352 (is_implicated_in) | |
| Disease | Hirschsprung Disease | 1.25e-03 | 31 | 203 | 3 | C0019569 | |
| Disease | breast size | 1.33e-03 | 69 | 203 | 4 | EFO_0004884 | |
| Disease | fasting blood insulin measurement | 1.33e-03 | 69 | 203 | 4 | EFO_0004466 | |
| Disease | 22q11 partial monosomy syndrome | 1.64e-03 | 9 | 203 | 2 | C3266101 | |
| Disease | gastritis | 1.64e-03 | 9 | 203 | 2 | EFO_0000217 | |
| Disease | Renal Cell Carcinoma | 1.96e-03 | 128 | 203 | 5 | C0007134 | |
| Disease | mood instability measurement | 1.96e-03 | 128 | 203 | 5 | EFO_0008475 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.96e-03 | 128 | 203 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.96e-03 | 128 | 203 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.96e-03 | 128 | 203 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.96e-03 | 128 | 203 | 5 | C1306837 | |
| Disease | Hashish Abuse | 2.04e-03 | 10 | 203 | 2 | C0018614 | |
| Disease | Cannabis Abuse | 2.04e-03 | 10 | 203 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 2.04e-03 | 10 | 203 | 2 | C0236735 | |
| Disease | Brain hemorrhage | 2.04e-03 | 10 | 203 | 2 | C0553692 | |
| Disease | Asymmetric crying face association | 2.04e-03 | 10 | 203 | 2 | C0431406 | |
| Disease | 22q11 Deletion Syndrome | 2.04e-03 | 10 | 203 | 2 | C2936346 | |
| Disease | Autistic Disorder | 2.29e-03 | 261 | 203 | 7 | C0004352 | |
| Disease | serum metabolite measurement | CYP1A2 PSEN2 CYP3A5 MCCC1 FMO6P SULT1A2 CLIC5 PTPRH ARID5B GPD2 FMO3 TMEM233 MAP4K5 DIP2C MYOM2 | 2.39e-03 | 945 | 203 | 15 | EFO_0005653 |
| Disease | Congenital Nonbullous Ichthyosiform Erythroderma | 2.49e-03 | 11 | 203 | 2 | C0079154 | |
| Disease | Bipolar I disorder | 2.49e-03 | 11 | 203 | 2 | C0853193 | |
| Disease | Alzheimer disease, polygenic risk score | EPHB4 ZNF804A OLFM3 CLIC5 NUP160 CHRNA6 RET GRM8 SPPL2A RIMS1 GABBR1 | 2.59e-03 | 586 | 203 | 11 | EFO_0030082, MONDO_0004975 |
| Disease | lymphocyte count | EPPK1 PHF19 CYP3A5 MCCC1 RRM1 PTPRH UMODL1 PIK3CD ARID5B MED12L ABCD1 NUP160 IL31RA TCF7L2 DNAH10 SPPL2A ARVCF MAP4K5 LY9 TUBD1 | 2.80e-03 | 1464 | 203 | 20 | EFO_0004587 |
| Disease | Cocaine Dependence | 2.80e-03 | 139 | 203 | 5 | C0600427 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 2.82e-03 | 41 | 203 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 2.82e-03 | 41 | 203 | 3 | C0858252 | |
| Disease | Autism Spectrum Disorders | 2.85e-03 | 85 | 203 | 4 | C1510586 | |
| Disease | Hirschsprung's disease (implicated_via_orthology) | 2.97e-03 | 12 | 203 | 2 | DOID:10487 (implicated_via_orthology) | |
| Disease | Akinetic-Rigid Variant of Huntington Disease | 2.97e-03 | 12 | 203 | 2 | C0751207 | |
| Disease | Juvenile Huntington Disease | 2.97e-03 | 12 | 203 | 2 | C0751208 | |
| Disease | X-12707 measurement | 2.97e-03 | 12 | 203 | 2 | EFO_0800720 | |
| Disease | Huntington Disease, Late Onset | 2.97e-03 | 12 | 203 | 2 | C0393574 | |
| Disease | high grade glioma (is_implicated_in) | 3.02e-03 | 42 | 203 | 3 | DOID:3070 (is_implicated_in) | |
| Disease | testosterone measurement | DOCK4 RYK NDUFS5 NF1 ARID5B HS3ST4 USH2A NUP160 ARHGAP21 MED12 FMO3 NPEPPS NTAQ1 RDH16 HMCN1 SYTL4 MAP4K5 MCM9 | 3.22e-03 | 1275 | 203 | 18 | EFO_0004908 |
| Disease | eosinophil count | PSEN2 FOXA1 SPATA2 ITIH4 NDUFS5 STAT4 EHD4 CLIC5 GLDC PIK3CD MED12L SIK2 CCR6 FOXO1 FPR3 ARVCF MAP4K5 TUBD1 NNT GABBR1 | 3.36e-03 | 1488 | 203 | 20 | EFO_0004842 |
| Disease | Malignant Head and Neck Neoplasm | 3.45e-03 | 44 | 203 | 3 | C0278996 | |
| Disease | coffee consumption measurement, tea consumption measurement | 3.45e-03 | 44 | 203 | 3 | EFO_0006781, EFO_0010091 | |
| Disease | serum IgG glycosylation measurement | VPS13C MTSS1 ZNF804A UMODL1 FMN1 ARID5B USH2A STAB2 DNAH10 SAMD5 | 3.52e-03 | 523 | 203 | 10 | EFO_0005193 |
| Disease | Mammary Carcinoma, Human | EPHB4 FOXA1 ABCB1 SULT1A1 BRCA2 PIK3CA MED12 ATG10 UBLCP1 PAK1 | 3.62e-03 | 525 | 203 | 10 | C4704874 |
| Disease | Mammary Neoplasms, Human | EPHB4 FOXA1 ABCB1 SULT1A1 BRCA2 PIK3CA MED12 ATG10 UBLCP1 PAK1 | 3.62e-03 | 525 | 203 | 10 | C1257931 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.67e-03 | 148 | 203 | 5 | C0279702 | |
| Disease | Mammary Neoplasms | EPHB4 FOXA1 ABCB1 SULT1A1 BRCA2 PIK3CA MED12 ATG10 UBLCP1 PAK1 | 3.71e-03 | 527 | 203 | 10 | C1458155 |
| Disease | alcohol use disorder measurement | 3.75e-03 | 214 | 203 | 6 | EFO_0009458 | |
| Disease | Thrombus | 3.92e-03 | 46 | 203 | 3 | C0087086 | |
| Disease | ascorbic acid 3-sulfate measurement | 4.06e-03 | 14 | 203 | 2 | EFO_0800173 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PVGSWYNVTILVKMD | 166 | Q5DID0 | |
| KSWLVPTQYILGLFM | 141 | O00400 | |
| MDIWVPIKIGALTYF | 281 | Q5FVE4 | |
| VAQVWPFLGQYMEKL | 146 | Q9BSJ8 | |
| YLTVKVWDLNMEARP | 301 | Q9Y2T4 | |
| SGAVWKQIYMDLGIP | 361 | P29374 | |
| QVYWLGPLTGMVLAV | 221 | Q8IXF9 | |
| GTLWNLSSYEPLKMV | 466 | O00192 | |
| WYIQGASSPKDMVII | 281 | Q9NY47 | |
| DWSYLVPMTELKPGN | 131 | Q8N6M5 | |
| GKILPEYLSNWTMEK | 341 | O95831 | |
| MWGTYEGQLPVLAIT | 71 | P20815 | |
| LRYKFSWSPVGVLMN | 646 | Q9UDR5 | |
| YQTVSEPIRWKLLML | 201 | P51684 | |
| ITWHKNMSVLIPEEY | 561 | Q86UQ4 | |
| YKMRLLQGPWDTITQ | 136 | Q9H0Y0 | |
| LEGQKLQEMVLWAPY | 3836 | Q96M86 | |
| MQEYIAVVKKLDPGW | 111 | Q9BR61 | |
| QVYWLGPLTGMVLAV | 221 | A6NM10 | |
| IPAEMTGLWRYLKNA | 366 | Q9NZA1 | |
| MLLVGKDGNVKSWYP | 866 | Q76M96 | |
| IVKGLYTLRPEWVQM | 286 | Q86Y37 | |
| AYKWKETLFSVMPGL | 811 | Q14624 | |
| RYSNKELKGMLVWSP | 66 | Q8IZ40 | |
| IMWKLTRDETNYGIP | 41 | P63244 | |
| ISWSLMYLVTKPEIQ | 326 | P05177 | |
| SGEKEITPSYVFMVW | 1341 | Q68DA7 | |
| MVKLANPLYTEWILE | 1 | Q8WYB5 | |
| LYNKIFWKSILMGPV | 71 | Q8N109 | |
| MKLNLTEWPYFVVGV | 701 | P08183 | |
| KYVWSASGLLMVAVP | 336 | P33897 | |
| LLYLLVKTEIPNWMA | 316 | Q96NW4 | |
| KSLVGTPYWMAPEVI | 601 | Q9P286 | |
| DQWLQLLRTYVGPMT | 621 | O60568 | |
| PVKMGVYITHPAWEV | 56 | Q14517 | |
| VLQWVLKYLLLGPMS | 21 | Q96PD6 | |
| AYKRESPLIVNTMGW | 396 | Q5SY16 | |
| EIWYTTATIPKMLSN | 86 | Q8NGY3 | |
| KPWSGISVYMFNLAL | 81 | P47900 | |
| IYDLTAMKVPTAIWA | 326 | Q5VXI9 | |
| NLPTAISDWLYVKQM | 246 | P31513 | |
| IFFLPWQKMTIAGTT | 341 | P43304 | |
| LAKYSVPMVRATWLI | 146 | Q86YW9 | |
| MFYGEPRKLLTQDWV | 236 | P43362 | |
| RTVGLSVMYAPWKPT | 316 | P20916 | |
| LTPAWMENPYIKVDT | 126 | P54760 | |
| KPKMQSLVQWGLDSY | 86 | Q9BUR5 | |
| MTYWRLENIAKTEPP | 111 | Q8NI17 | |
| WERMNLKVPIYFSTG | 256 | Q5TA45 | |
| PTASQMKSLVYWREI | 611 | P59045 | |
| EPWKLYATVGLLVGM | 706 | Q9UBS5 | |
| VQRDKPLLIMEYWVG | 291 | Q8NCI6 | |
| IEPSVSLWQFYLSKM | 301 | P04035 | |
| FDLPTTVSMIKLWNY | 1491 | O60303 | |
| SPWALINSSIYAMKE | 66 | Q92485 | |
| PYELIGILMAVWLKE | 256 | P25089 | |
| PLIGYIMDWRIKDCV | 371 | O75387 | |
| YFMAIGEELVSIPWK | 386 | O94919 | |
| LYNKIFWKSILMGPV | 71 | Q8NHK3 | |
| KLNAPIWYLVSVMET | 466 | O95382 | |
| IIDGYITPMDFIWLK | 641 | Q86YR7 | |
| MLVNLWGPDKTISYV | 81 | Q9Y3N9 | |
| TTMPKALANLWLGYS | 96 | Q8NGF0 | |
| EFVLTGLTYQPEWKM | 16 | Q8NGV7 | |
| FQTIISDMKGSYPVW | 16 | O43312 | |
| LVSPVTIATYMKGQW | 71 | P35408 | |
| YLKAPMILNGVCVIW | 96 | Q13951 | |
| FGWLIPKVMRIYDTQ | 346 | O00748 | |
| FPLESWQIGKIGTVM | 101 | P30046 | |
| QEPGFAKMISTVVWL | 126 | O14626 | |
| GPISKTINMLVRWYV | 336 | P48449 | |
| GLILPTELWTAMLNY | 591 | Q9Y4C0 | |
| LKIMYAAVVPWSAAV | 801 | P50748 | |
| LAKYTVPVMRAAWLI | 146 | Q93074 | |
| SYIMNGIIKWGDPVT | 501 | P46459 | |
| YGALMWSLGKVINTP | 236 | Q9H223 | |
| VLPSFISDWLYVQKM | 246 | O60774 | |
| LYEIAMAWNLVKPVT | 366 | Q9Y4A0 | |
| LEIWYTSVTVPKMLA | 71 | Q8NGQ2 | |
| LEEQTMGKYNWVTTP | 911 | Q9BZA7 | |
| KPIGFTMYTTCIIWL | 781 | O00222 | |
| KDGQMLSPSSLYTIW | 1836 | A2RRP1 | |
| PYMNGETSTKSLWVI | 316 | P42336 | |
| PVLAYRTVVPWKTNM | 151 | Q15722 | |
| TGYPKPKIAWTVNDM | 636 | Q96RW7 | |
| SAMRKIVSILNPIYW | 4921 | Q96RW7 | |
| LDLSSMVIGWYKLFP | 1646 | Q86UR5 | |
| QITSPGYALNSMKVW | 661 | Q8NB91 | |
| YGPKVDIWSLGIMAI | 441 | Q13153 | |
| APSKMLTLSEIYQWI | 186 | P55317 | |
| MVKLANPLYTEWILE | 1 | Q92794 | |
| LWYTATTIPKMLSNI | 71 | Q8NGY6 | |
| KIMRLLWATSYCGPQ | 211 | Q5W5W9 | |
| SQPKELYTEMAVIWL | 4186 | Q9P2D7 | |
| TKALLKYNGMITWTP | 136 | Q15825 | |
| LTLSQIYEWMVKSVP | 181 | Q12778 | |
| LMNDFYPGILTVTWK | 136 | P15814 | |
| MIWIKGTEPLRIQYS | 266 | Q8N9C0 | |
| LPKVTWYKDGMEVTE | 636 | Q8N9C0 | |
| MWIPTEHEKYGVVIA | 1 | Q8N1I0 | |
| GWLKIKPEYVSGLMD | 446 | P49917 | |
| YPIQWMEKTSSGLYI | 2826 | P51587 | |
| WPKLELSLQYDMALA | 551 | Q9HCG7 | |
| LMWIPVYGGKTEEVV | 656 | Q05707 | |
| IDLTVNILTMGYWPT | 521 | Q13619 | |
| PYSLMKVNPLSWIQK | 566 | Q9Y2E4 | |
| YQWEVIMPALEGKNI | 6 | Q96C10 | |
| ALMGSIISNLPSWIY | 276 | Q53GQ0 | |
| PMAALYQVLNKWTLG | 91 | P08908 | |
| LYVSGPTLSKMWKQQ | 576 | Q96GE4 | |
| WGPLLAIMVYDVFGK | 356 | P21554 | |
| KGITMYNKAVWSPEP | 106 | O94769 | |
| VSVHYDPMIAKLVVW | 426 | Q96RQ3 | |
| TVMYTWTPLQKEAVV | 391 | Q9HBG7 | |
| IMTGWNPVRLYEQLL | 546 | Q8NEL9 | |
| PKYMPVQSWELLTQT | 2766 | Q9NYC9 | |
| NLWLKMGKYFSLIPT | 251 | Q9HBU6 | |
| DKLIMVWKRATYIGP | 91 | P54198 | |
| ETASWIIMNKPVYIT | 246 | Q9NS85 | |
| PDTLKSLGNWMVYFL | 4291 | Q8IVF4 | |
| WNKYMIQDLTEIGTP | 211 | Q9Y2H2 | |
| LLQMGLPDQLYSLVW | 146 | Q9Y2W3 | |
| TLWELMTLGQTPYVD | 531 | P34925 | |
| EMYWKYEINGLTPTT | 3121 | Q6ZTR5 | |
| TWTKQMGFPLIYVEA | 496 | P55786 | |
| QIYAVPWQGTMTLSK | 126 | P01034 | |
| LEWYRNVMPKTLDGQ | 241 | Q9Y661 | |
| QDTLEVMKSWSTGYP | 376 | Q96PB7 | |
| YAVFISNERKMIPIW | 51 | Q96HA8 | |
| ALQSGIVLLQWYEPM | 641 | Q9Y4K4 | |
| MSFLEIWYVSDITPK | 66 | Q6IFH4 | |
| IWYVSDITPKMLEGF | 71 | Q6IFH4 | |
| RYWPNILGKTTMVSN | 2321 | Q12923 | |
| YKIDPSTLQMWANIL | 851 | O15294 | |
| EIWYVTVTIPKMLAG | 71 | O95222 | |
| NKLYVIGGWTPQMDL | 436 | Q3ZCT8 | |
| ASAVYIKMSPELLGW | 266 | Q6ZRI0 | |
| SISPQMWQLLGILYE | 666 | O15397 | |
| TATIPKMLGIFWFNT | 81 | Q6IFG1 | |
| DDLTIYGIVMQRWKP | 236 | Q9NXL9 | |
| LTWQKLAPISIMYQI | 131 | P03891 | |
| MPVVITVLNSYSGWA | 831 | Q13423 | |
| VTRPLMDYLPTWQKI | 316 | Q9Y5Y5 | |
| MVDRWPETGYVKKLQ | 46 | Q5JSS6 | |
| TGEEVSLWQKMRQYP | 636 | Q96C24 | |
| YKGVPAITQMVGELW | 281 | A4D263 | |
| ISYVSMNPQKLLISW | 4271 | O75445 | |
| VPMPKNYLWLTIVSC | 31 | B4DJY2 | |
| ITYPKSGTTWMIEII | 66 | O00204 | |
| SGMELQSWYPVIKQE | 371 | P12757 | |
| MAGILEYLMNWPKSS | 156 | Q5TGI4 | |
| LVYMTPEQSANLLKW | 201 | Q9UIC8 | |
| GTYAWMAPEVIKSSL | 306 | Q5TCX8 | |
| LVDAIMYWVSPSPAK | 301 | O75452 | |
| NLKMLRIVEPYVTWG | 136 | Q6DKI1 | |
| WTMEGYLYVQEKRPL | 266 | A6NI28 | |
| TMPEQQLLKPTEWSY | 186 | O60861 | |
| RWLTIQSGEQPYKMA | 16 | O43920 | |
| YQAMWKGVLRPGTAL | 2246 | P58107 | |
| IYQAMWKGVLRPGTA | 2781 | P58107 | |
| SIYQAMWKGVLRPGT | 3311 | P58107 | |
| IYQAMWKGVLRPGTA | 3846 | P58107 | |
| YQAMWKGVLRPGTAL | 4381 | P58107 | |
| PQLDIWSMGVVLYVL | 196 | Q9H0K1 | |
| SLLVYMNLEKIWNGP | 181 | Q8WUT9 | |
| MSFLEIWYVSDITPK | 66 | Q8NGW1 | |
| IWYVSDITPKMLEGF | 71 | Q8NGW1 | |
| GLNWPEMITAITSYL | 851 | Q12769 | |
| LLNRPSVGLVQSWYM | 71 | Q15120 | |
| YPKSGTTWVSQILDM | 46 | P0DMN0 | |
| YPKSGTTWVSQILDM | 46 | P0DMM9 | |
| YPKSGTTWVSEIIDM | 46 | O43704 | |
| SFILSGYVIMWNKAI | 186 | Q9Y2K9 | |
| QYVPTWSKEMVALLR | 316 | Q86UX6 | |
| YITLSPQDINTKWDM | 606 | Q08043 | |
| RIPYLGFKQINLWTM | 341 | Q14865 | |
| MAYLSIPGTAKVGTW | 551 | Q14CN2 | |
| QPSGLWKLYSLMTST | 51 | Q6ZU45 | |
| MPVKYEENSLIWVAV | 161 | O75829 | |
| LKMNQIIWPYGTGEV | 166 | Q9UJT1 | |
| MLETVGINLFLYPWK | 91 | Q9UM82 | |
| TKIGLCVNMRSLPWY | 166 | A6PVC2 | |
| CLPWNSMILIGKVYT | 236 | P00750 | |
| SLSGYQWILPTMLQV | 2226 | Q8N2C7 | |
| TAGWNIPMGLLYNKI | 476 | P02787 | |
| PKSGTTWVSEIVYMI | 46 | P49888 | |
| VSKGILQYDMWNVTP | 561 | P23921 | |
| VPSWSKVNQGLIRMY | 316 | Q15257 | |
| ELPMYRKGTVLIWQK | 231 | Q9NWX6 | |
| YPKSGTTWVSQILDM | 46 | P50225 | |
| YPKSGTTWVSQILDM | 46 | P50226 | |
| LPLWIDGYVMGFVSK | 566 | Q14765 | |
| PWSVGKSTMINYLLG | 101 | Q86TD4 | |
| MEPTYQLSRWTPVIK | 466 | Q15833 | |
| TLGDNITVKMYSPSW | 151 | Q8TCT8 | |
| YLQMKWPLLDVQAGS | 151 | Q9NQB0 | |
| TFWLPQLNGYMEKST | 21 | P03897 | |
| VSQVLSGYDWTLVPM | 76 | P56693 | |
| WLKMSYPAKVTLLGS | 176 | Q9NVV0 | |
| KQMYPSIQAKIWGSL | 1986 | P21359 | |
| QLKTGERCLYMWPSV | 431 | O00329 | |
| AVKMVLSYQPEELEW | 171 | Q5T6S3 | |
| WKGPLVLQQAYLIMI | 221 | P49810 | |
| LLLWCQMKTAGYPEV | 186 | Q9H254 | |
| VKDWDKYGLMPQVLR | 1646 | Q8WWQ8 | |
| LAAAWYVQIPGMEIK | 1846 | Q709C8 | |
| LTKPVNMLLEWTIYS | 586 | Q9BQI6 | |
| NKCIIPWYIMTSGRT | 156 | Q16222 | |
| ALPSTWIENKLYGMS | 1051 | P07949 | |
| SALPLGIYLATKFWM | 356 | Q8IUH5 | |
| LITYLEQGKEPWNMK | 61 | Q05481 | |
| YQWLMPELHTKEQIL | 76 | Q8NF99 | |
| MALPIIVKWGGQEYS | 1 | Q8WVY7 | |
| TKTALMSLFGIPLWY | 636 | O94901 | |
| YLVRSGMKQWVPVLQ | 291 | Q8TB96 | |
| VGGSIRPWKQMYVVL | 951 | Q5T5U3 | |
| SYPATITTIWDGMKV | 726 | Q9HD43 | |
| MVNLSIYWIIGNTSP | 236 | Q7Z769 | |
| MLSPGVESQLYKLPW | 56 | Q96SA4 | |
| QWKSSDTLPVYDTLM | 721 | Q5FWF4 | |
| VLQWPSEMLVYTTTK | 436 | Q7Z570 | |
| MLVNAIFPIYTTGKW | 221 | Q8NFZ6 | |
| GSSSILPISWAYIKM | 806 | P23378 | |
| PTYNVKDMLVPTAVW | 326 | P38571 | |
| YNITKMEVPTAIWNG | 326 | Q5VXJ0 | |
| DTSLVMLWKAPVYSG | 826 | P54296 |